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Introduction
Being involved in many essential cellular processes, 
Membrane Proteins (MPs) constitute one of 
the most important therapeutic targets, such 
as G protein-coupled receptors (GPCR), small 
molecule transporter or ion channels [1-3]. A 
detailed knowledge of their structure and activity is 
essential to design new therapeutic or biomimetic 
agents and therefore plays a significant role in the 
drug discovery process.
The major difficulties frequently encountered 
during MPs in vitro study are mainly due to their 
partially hydrophobic surfaces, flexibility and lack 
of stability. As a consequence, less than 1% of all 
solved protein crystal structures are MPs [4], 
witnessing how challenging is their expression, 
solubilisation, purification and crystallisation. 
Protein overexpression in E. coli is a very common 
method as it is quite inexpensive, easy to use, and 
can provide results in a reasonable lapse of time. 
However, the production of MPs from bacterial 
membrane is often toxic, and generally expression 
yields tend to be limited.
A well-established alternative is based on the 
formation of inactive aggregates called inclusion 
bodies (IBs) in the cell cytosol. Subsequently, a 
refolding step from IB is needed but it often turns 
to be a difficult task [5]. Whilst the refolding of 
soluble globular proteins from IB has become 
routine, much fewer examples of MPs in vitro 
refolding have indeed been reported.
Conventional protocols include solubilizing IB with 
high concentrations of denaturant, followed by the 
lowering of the denaturant concentration, and the 
addition of detergents that simulate the membrane 
environment. Unfortunately, this approach 
frequently fails due to the disposition of proteins to 
aggregate upon the removal of denaturant, and one 
has to fall back on a time-consuming and inefficient 
trial-and-error strategy. In order to circumvent 
these shortcomings, the development of new 
efficient refolding techniques is urgently awaited. 
That is, the real challenge is to develop universal 
methods for MPs.
The so-called artificial chaperone-assisted 
refolding procedure based on the stripping-off 
effect of cyclodextrins has already been successfully 
used to refold several types of globular proteins, 
but up to now only few publications refer to the 
adaptation of this protocol to MPs [6]. For instance, 
the amphipathic polymer Apol A8-35 is able to 
refold both α-helical and β-barrel MPs [7] though 
solubility issues may arise in particular conditions. 
Other non-conventional approaches were developed 
to stabilize MPs: nanodiscs, fluorinated surfactants, 
lipopeptides, but none of them has proved its abilities 
to refold several types of MPs [8].
In that context, we have successfully demonstrated 
the reliability of a genuine protein refolding 
procedure based on the synergistic association of a 
detergent and a co-solvent.
Results
The powerful denaturant Sodium Dodecyle Sulfate 
(SDS), and the 2-Methyl-2,4-PentaneDiol (MPD) 
diol-type co-solvent are both known to affect 
the structure and solubility of proteins. More 
astonishing is that they show totally unexpected 
properties when combined in appropriate 
proportions. An optimal concentration of MPD, 
i.e. 1-1.5M, seems to be essential for the refolding, 
whatever the protein, in conjunction with mM 
concentrations of SDS.
Remarkably, our method has successfully been 
applied to several peptides and proteins featuring 
diverse structures and properties [9-14]. Indeed, 
several monomeric β-barrel MPs with a variable 
number of transmembrane (TM) strands have 
been refolded: PagP (8TM), a VDAC (19TM), FhuA 
(22TM). Oligomeric MPs have also been recovered: 
the heptameric hemolysin (14TM) and the trimeric 
Omp2a (16TM). Aside, our seminal technique 
was recently used for diverse applications, taking 
advantage of its refolding, solubilizing and 
stabilizing properties [10,15-17]. Moreover, crystal 
structures of both the globular hen-egg lysozyme 
[18] and the membrane protein PagP [19] have 
clearly established the preservation of the native 
state in a SDS-MPD mixture. They also show that 
MPD lowers or annihilates the interactions between 
the denaturant and the protein.
Unlike the other refolding methods, the originality 
of our process is that MPD is used to modify the 
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denaturant properties without having to reduce its concentration. 
MPD is able to transform the harsh denaturing SDS character into a 
gentle non-denaturing detergent that softly interacts with the protein. 
Furthermore, this method has been demonstrated to be compatible 
with various characterization techniques, such as Circular Dichroism, 
Dynamic Light Scattering, fluorescence, crystallography and 
transmission electron microscopy. On the top of that, our protocol 
is particularly inexpensive with respect to other available techniques.
Combining spectroscopic and computational approaches, we have 
refined our understanding of the molecular interactions underlying 
the SDS-MPD association [20-22]. By shielding the negative charge on 
SDS headgroups and protecting the hydrophobic tail of the detergent 
from water, MPD molecules can separate SDS molecules from each 
other, leading to the SDS micelle dismantlement. In a first stage, 
the aggregation of proteins is prevented by the addition of detergent 
molecules that shield the hydrophobic regions of the denatured 
protein. Afterwards, the co-solvent alters the surfactant denaturing 
properties by stripping it away from the protein-detergent complexes, 
and allowing the subsequent refolding. The performance and specific 
properties of the co-solvent MPD are hypothesized to rely on its 
specifically balanced lipophilic–hydrophilic character.
Perspectives
The efficient and inexpensive SDS-MPD method has already 
given promising results on the refolding of β-barrel MPs. Having 
already demonstrated that MPD is able to protect the a-helical 
bacteriorhodopsin [9], we now intend to refold such type of MPs, like 
GPCRs, that will consequently be available for analysis and pave the 
way towards the design of new drugs.
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